Author:
Reipold Elena Ivanova,Farahat Ahmed,Elbeeh Amira,Soliman Reham,Aza Elkin Bermudez,Jamil Muhammad S.,Johnson Cheryl Case,Shiha Gamal,Easterbrook Philippa
Abstract
Abstract
Background
Self-testing for hepatitis C virus antibodies (HCVST) may be an additional strategy to expand access to hepatitis C virus (HCV) testing and support elimination efforts. We conducted a study to assess the usability and acceptability of HCVST among the general population in a semi-rural, high-HCV prevalence region in Egypt.
Methods
An observational study was conducted in two hospitals in the Nile Delta region. A trained provider gave an in-person demonstration on how to use the oral fluid HCVST followed by observation of the participant performing the test. Usability was assessed by observing errors made and difficulties faced by participants. Acceptability of HCV self-testing was assessed using an interviewer-administered semi-structured questionnaire.
Results
Of 116 participants enrolled, 17 (14.6%) had received no formal education. The majority (72%) of participants completed all testing steps without any assistance and interpreted the test results correctly. Agreement between participant-reported HCVST results and interpretation by a trained user was 86%, with a Cohen’s kappa of 0.6. Agreement between participant-reported HCVST results and provider-administered oral fluid HCV rapid test results was 97.2%, with a Cohen’s kappa of 0.75. The majority of participants rated the HCVST process as easy (53%) or very easy (44%), and 96% indicated they would be willing to use HCVST again and recommend it to their family and friends.
Conclusion
Our study demonstrates the high usability and acceptability of oral fluid HCVST in a general population. Further studies are needed to establish the optimal positioning of self-testing alongside facility-based testing to expand access to HCV diagnosis in both general and high-risk populations.
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health
Reference37 articles.
1. Progress report on HIV, viral hepatitis and sexually transmitted infections 2019: accountability for the global health sector strategies, 2016-2021. Geneva: World Health Organization; 2019. https://apps.who.int/iris/handle/10665/324797. Accessed Feb 2021.
2. Global health sector strategy on viral hepatitis 2016-2021. Geneva: World Health Organization; 2020. http://apps.who.int/iris/bitstream/handle/10665/246177/WHO-HIV-2016.06-eng.pdf?sequence=1. Accessed Feb 2021.
3. Waked I, Esmat G, Elsharkawy A, El-Serafy M, Abdel-Razek W, Ghalab R, et al. Screening and treatment program to eliminate hepatitis C in Egypt. N Engl J Med. 2020;382(12):1166–74. https://doi.org/10.1056/NEJMsr1912628.
4. Guidelines on hepatitis B and C testing. Geneva: World Health Organization; 2017. http://apps.who.int/iris/bitstream/handle/10665/254621/9789241549981-eng.pdf?sequence=1. Accessed Feb 2021.
5. Easterbrook PJ. WHO guidelines development group. WHO to test and how to test for chronic hepatitis C infection - 2016 WHO testing guidance for low- and middle-income countries. J Hepatol. 2016;65(1 Suppl):S46–66. https://doi.org/10.1016/j.jhep.2016.08.002.
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献